RIMONABANT

Acomplia
Active molecule : Rimonabant which is anorexigen inhibitor of type I cannabinoid receptors (receptors CBI). These receptors are involved in the regulation of anger and in the metabolism of glucose and lipids.
Acomplia is a drug used in the treatment of obese or overweight patients, or patients affected by type 2 diabetes.